Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations

Abstract

Objective This study aims to provide a preliminary discussion of the molecular basis of FV deficiency caused by compound heterozygous mutations in two Chinese families.

Methods Relative coagulation index was measured by the one-stage clotting method and the FV:Ag was measured by ELISA. All exons and flanking regions of the F5 gene were amplified by PCR and directly sequenced. ClustalX-2.1-win was used to analyze the conservation of mutations. The online software was used to predict the pathogenicity of mutations. PyMOL was used to analyze the variation in the spatial structure of the FV protein before and after mutations. Calibrated automated thrombogram was used to analyze the function of the mutant protein.

Results Phenotyping suggested that both probands had a simultaneous decrease in FV:C and FV:Ag. Their genetic tests showed that proband A had a missense mutation p.Ser111Ile in exon 3 and a polymorphism p.Arg2222Gly in exon 25. At the same time, the proband B had a missense mutation p.Asp96His in exon 3 and a frame-shift mutation p.Pro798Leufs*13 in exon 13. Meanwhile, the p.Ser111Ile is conserved among homologous species. The bioinformatics and protein model analysis revealed that p.Ser111Ile and p.Pro798Leufs*13 were pathogenic and could affect the structure of the FV protein. The thrombin generation test revealed that the clotting function of proband A and B had been affected.

Conclusion These four mutations may be responsible for the reduction of FV levels in two Chinese families. Moreover, the p.Ser111Ile mutation is a novel pathogenic variant that has not been reported.

Keywords

coagulation factor V deficiency - F5 gene - bioinformatics - thrombin generation

Ethical Approval

Our study was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University (China).

Publication History

Received: 14 December 2022

Accepted: 03 May 2023

Article published online:
15 June 2023

• References

• 1 Tabibian S, Shiravand Y, Shams M. et al. A comprehensive overview of coagulation factor V and congenital factor V deficiency. Semin Thromb Hemost 2019; 45 (05) 523-543
• 2 Norstrøm E, Thorelli E, Dahlbäck B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 2002; 100 (02) 524-530
• 3 Dong R, Chen G, Jin Y, Wang M, Cheng X, Chen Y. Significance of the p.Phe218Ser and p.Gly304Glu F5 variants in hereditary factor V deficiency. Acta Haematol 2021; 144 (06) 712-716
• 4 Batsuli G, Kouides P. Rare coagulation factor deficiencies (factors VII, X, V, and II). Hematol Oncol Clin North Am 2021; 35 (06) 1181-1196
• 5 Deng Y, Zhu J, Gong Y. et al. Hereditary factor V deficiency from heterozygous mutations with a novel variant p.Pro798Leufs∗13 in the F5 gene. Blood Coagul Fibrinolysis 2021; 32 (07) 513-518
• 6 Delev D, Pavlova A, Heinz S. et al. Modelling and expression studies of two novel mutations causing factor V deficiency. Thromb Haemost 2008; 100 (05) 766-772
• 7 Ruben EA, Rau MJ, Fitzpatrick JAJ, Di Cera E. Cryo-EM structures of human coagulation factors V and Va. Blood 2021; 137 (22) 3137-3144
• 8 Takeyama M, Nogami K, Okuda M. et al. Selective factor VIII and V inactivation by iminodiacetate ion exchange resin through metal ion adsorption. Br J Haematol 2008; 142 (06) 962-970
• 9 Adams TE, Hockin MF, Mann KG, Everse SJ. The crystal structure of activated protein C-inactivated bovine factor Va: implications for cofactor function. Proc Natl Acad Sci U S A 2004; 101 (24) 8918-8923
• 10 Liu HC, Lin TM, Eng HL, Lin YT, Shen MC. Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency. Thromb Res 2014; 134 (01) 153-159
• 11 Orban T, Kalafatis M, Gogonea V. Completed three-dimensional model of human coagulation factor Va. Molecular dynamics simulations and structural analyses. Biochemistry 2005; 44 (39) 13082-13090
• 12 Chegeni R, Kazemi B, Hajifathali A, Pourfathollah A, Lari GR. Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis. Thromb Res 2007; 119 (02) 189-193
• 13 Yamazaki T, Nicolaes GA, Sørensen KW, Dahlbäck B. Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype. Blood 2002; 100 (07) 2515-2521
• 14 Liu HC, Shen MC, Eng HL, Wang CH, Lin TM. Asp68His mutation in the A1 domain of human factor V causes impaired secretion and ineffective translocation. Haemophilia 2014; 20 (04) e318-e326
• 15 Kurosaki T, Popp MW, Maquat LE. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol 2019; 20 (07) 406-420